Cargando…
Mesencure—an enhanced cell therapy explicitly developed for treating acute respiratory distress in covid-19: from benchtop to bedside
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111922/ http://dx.doi.org/10.1016/S1465324921002784 |
| _version_ | 1783690591795675136 |
|---|---|
| author | Bronshtein, T. Ben David, D. Novak, A. Kivity, V. Hamoud, S. Hayek, T. Meretzki, S. |
| author_facet | Bronshtein, T. Ben David, D. Novak, A. Kivity, V. Hamoud, S. Hayek, T. Meretzki, S. |
| author_sort | Bronshtein, T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8111922 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | International Society for Cell & Gene Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81119222021-05-11 Mesencure—an enhanced cell therapy explicitly developed for treating acute respiratory distress in covid-19: from benchtop to bedside Bronshtein, T. Ben David, D. Novak, A. Kivity, V. Hamoud, S. Hayek, T. Meretzki, S. Cytotherapy Article International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2021-05 2021-05-11 /pmc/articles/PMC8111922/ http://dx.doi.org/10.1016/S1465324921002784 Text en Copyright © 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Bronshtein, T. Ben David, D. Novak, A. Kivity, V. Hamoud, S. Hayek, T. Meretzki, S. Mesencure—an enhanced cell therapy explicitly developed for treating acute respiratory distress in covid-19: from benchtop to bedside |
| title | Mesencure—an enhanced cell therapy explicitly developed for treating acute respiratory distress in covid-19: from benchtop to bedside |
| title_full | Mesencure—an enhanced cell therapy explicitly developed for treating acute respiratory distress in covid-19: from benchtop to bedside |
| title_fullStr | Mesencure—an enhanced cell therapy explicitly developed for treating acute respiratory distress in covid-19: from benchtop to bedside |
| title_full_unstemmed | Mesencure—an enhanced cell therapy explicitly developed for treating acute respiratory distress in covid-19: from benchtop to bedside |
| title_short | Mesencure—an enhanced cell therapy explicitly developed for treating acute respiratory distress in covid-19: from benchtop to bedside |
| title_sort | mesencure—an enhanced cell therapy explicitly developed for treating acute respiratory distress in covid-19: from benchtop to bedside |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111922/ http://dx.doi.org/10.1016/S1465324921002784 |
| work_keys_str_mv | AT bronshteint mesencureanenhancedcelltherapyexplicitlydevelopedfortreatingacuterespiratorydistressincovid19frombenchtoptobedside AT bendavidd mesencureanenhancedcelltherapyexplicitlydevelopedfortreatingacuterespiratorydistressincovid19frombenchtoptobedside AT novaka mesencureanenhancedcelltherapyexplicitlydevelopedfortreatingacuterespiratorydistressincovid19frombenchtoptobedside AT kivityv mesencureanenhancedcelltherapyexplicitlydevelopedfortreatingacuterespiratorydistressincovid19frombenchtoptobedside AT hamouds mesencureanenhancedcelltherapyexplicitlydevelopedfortreatingacuterespiratorydistressincovid19frombenchtoptobedside AT hayekt mesencureanenhancedcelltherapyexplicitlydevelopedfortreatingacuterespiratorydistressincovid19frombenchtoptobedside AT meretzkis mesencureanenhancedcelltherapyexplicitlydevelopedfortreatingacuterespiratorydistressincovid19frombenchtoptobedside |